Four notes:
1. First quarter sales grew 65 percent year-over-year, according to a news relese.
2. Bone growth therapy sales grew 14 percent year-over-year. Growth was largely driven from spine and fracture product sales.
3. U.S. spinal implant sales rose 18 percent from the first quarter of 2022. Global spine sales were $149.2 million, an 80.5 percent increase year-over-year.
4. Orthofix saw a net loss of $60.9 million. In the first quarter of 2022, net losses were $4.5 million.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
